These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 10681309)

  • 21. Nucleoside reverse transcriptase inhibitors (NRTIs)-induced expression profile of mitochondria-related genes in the mouse liver.
    Desai VG; Lee T; Delongchamp RR; Leakey JE; Lewis SM; Lee F; Moland CL; Branham WS; Fuscoe JC
    Mitochondrion; 2008 Mar; 8(2):181-95. PubMed ID: 18313992
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Favorable interaction of beta-L(-) nucleoside analogues with clinically approved anti-HIV nucleoside analogues for the treatment of human immunodeficiency virus.
    Bridges EG; Dutschman GE; Gullen EA; Cheng YC
    Biochem Pharmacol; 1996 Mar; 51(6):731-6. PubMed ID: 8602867
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tempol protects cardiomyocytes from nucleoside reverse transcriptase inhibitor-induced mitochondrial toxicity.
    Liu Y; Shim E; Nguyen P; Gibbons AT; Mitchell JB; Poirier MC
    Toxicol Sci; 2014 May; 139(1):133-41. PubMed ID: 24591154
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Perspectives on the molecular mechanism of inhibition and toxicity of nucleoside analogs that target HIV-1 reverse transcriptase.
    Anderson KS
    Biochim Biophys Acta; 2002 Jul; 1587(2-3):296-9. PubMed ID: 12084471
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Zidovudine induces S-phase arrest and cell cycle gene expression changes in human cells.
    Olivero OA; Tejera AM; Fernandez JJ; Taylor BJ; Das S; Divi RL; Poirier MC
    Mutagenesis; 2005 Mar; 20(2):139-46. PubMed ID: 15784690
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacodynamic studies (PD) of didanosine (ddI) alone and in combination with azidothymidine (AZT) in human T-cells; a stochastic biochemical approach to antiretroviral nucleoside drug combination in inhibiting HIV-reverse transcriptase (RT).
    Periclou AP; Nandy P; Avramis VI
    In Vivo; 2000; 14(3):377-88. PubMed ID: 10904870
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mitochondrial toxicity in hearts of CD-1 mice following perinatal exposure to AZT, 3TC, or AZT/3TC in combination.
    Chan SS; Santos JH; Meyer JN; Mandavilli BS; Cook DL; McCash CL; Kissling GE; Nyska A; Foley JF; van Houten B; Copeland WC; Walker VE; Witt KL; Bishop JB
    Environ Mol Mutagen; 2007; 48(3-4):190-200. PubMed ID: 16395692
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficacy of zidovudine compared to stavudine, both in combination with lamivudine and indinavir, in human immunodeficiency virus-infected nucleoside-experienced patients with no prior exposure to lamivudine, stavudine, or protease inhibitors (novavir trial).
    Joly V; Flandre P; Meiffredy V; Brun-Vezinet F; Gastaut JA; Goujard C; Remy G; Descamps D; Ruffault A; Certain A; Aboulker JP; Yeni P;
    Antimicrob Agents Chemother; 2002 Jun; 46(6):1906-13. PubMed ID: 12019107
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Morphological and molecular course of mitochondrial pathology in cultured human cells exposed long-term to Zidovudine.
    Divi RL; Haverkos KJ; Humsi JA; Shockley ME; Thamire C; Nagashima K; Olivero OA; Poirier MC
    Environ Mol Mutagen; 2007; 48(3-4):179-89. PubMed ID: 16894629
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparative metabolism of the antiviral dimer 3'-azido-3'-deoxythymidine-P-2',3'-dideoxyinosine and the monomers zidovudine and didanosine by rat, monkey, and human hepatocytes.
    Pan-Zhou XR; Cretton-Scott E; Zhou XJ; Xie MY; Rahmani R; Schinazi RF; Duchin K; Sommadossi JP
    Antimicrob Agents Chemother; 1997 Nov; 41(11):2502-10. PubMed ID: 9371357
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of 2',3'-dideoxynucleosides on proliferation and differentiation of human pluripotent progenitors in liquid culture and their effects on mitochondrial DNA synthesis.
    Faraj A; Fowler DA; Bridges EG; Sommadossi JP
    Antimicrob Agents Chemother; 1994 May; 38(5):924-30. PubMed ID: 7520683
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antiretroviral nucleosides, deoxynucleotide carrier and mitochondrial DNA: evidence supporting the DNA pol gamma hypothesis.
    Lewis W; Kohler JJ; Hosseini SH; Haase CP; Copeland WC; Bienstock RJ; Ludaway T; McNaught J; Russ R; Stuart T; Santoianni R
    AIDS; 2006 Mar; 20(5):675-84. PubMed ID: 16514297
    [TBL] [Abstract][Full Text] [Related]  

  • 33. ATP-dependent removal of nucleoside reverse transcriptase inhibitors by human immunodeficiency virus type 1 reverse transcriptase.
    Naeger LK; Margot NA; Miller MD
    Antimicrob Agents Chemother; 2002 Jul; 46(7):2179-84. PubMed ID: 12069972
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Skeletal muscle mitochondria from AZT-treated rats have a diminished response to chronic electrical stimulation.
    McCurdy DT; Kennedy JM
    J Appl Physiol (1985); 1996 Jul; 81(1):326-34. PubMed ID: 8828681
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In vitro selection of mutations in the human immunodeficiency virus type 1 reverse transcriptase that decrease susceptibility to (-)-beta-D-dioxolane-guanosine and suppress resistance to 3'-azido-3'-deoxythymidine.
    Bazmi HZ; Hammond JL; Cavalcanti SC; Chu CK; Schinazi RF; Mellors JW
    Antimicrob Agents Chemother; 2000 Jul; 44(7):1783-8. PubMed ID: 10858331
    [TBL] [Abstract][Full Text] [Related]  

  • 36. 5-Chloro-2',3'-dideoxy-3'-fluorouridine (935U83), a selective anti-human immunodeficiency virus agent with an improved metabolic and toxicological profile.
    Daluge SM; Purifoy DJ; Savina PM; St Clair MH; Parry NR; Dev IK; Novak P; Ayers KM; Reardon JE; Roberts GB
    Antimicrob Agents Chemother; 1994 Jul; 38(7):1590-603. PubMed ID: 7526782
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fetal mitochondrial heart and skeletal muscle damage in Erythrocebus patas monkeys exposed in utero to 3'-azido-3'-deoxythymidine.
    Gerschenson M; Erhart SW; Paik CY; St Claire MC; Nagashima K; Skopets B; Harbaugh SW; Harbaugh JW; Quan W; Poirier MC
    AIDS Res Hum Retroviruses; 2000 May; 16(7):635-44. PubMed ID: 10791874
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Adenosine 3',5'-cyclic monophosphate (cAMP)-dependent phosphoregulation of mitochondrial complex I is inhibited by nucleoside reverse transcriptase inhibitors.
    Lund KC; Wallace KB
    Toxicol Appl Pharmacol; 2008 Jan; 226(1):94-106. PubMed ID: 17904600
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A novel point mutation at position 156 of reverse transcriptase from feline immunodeficiency virus confers resistance to the combination of (-)-beta-2',3'-dideoxy-3'-thiacytidine and 3'-azido-3'-deoxythymidine.
    Smith RA; Remington KM; Preston BD; Schinazi RF; North TW
    J Virol; 1998 Mar; 72(3):2335-40. PubMed ID: 9499094
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Increased long-term mitochondrial toxicity in combinations of nucleoside analogue reverse-transcriptase inhibitors.
    Walker UA; Setzer B; Venhoff N
    AIDS; 2002 Nov; 16(16):2165-73. PubMed ID: 12409738
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.